Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
15
TGA:15
Drug Approvals
OSPOMYV denosumab 60mg/1mL solution for injection pre-filled syringe (445963)
- Product Name
- OSPOMYV denosumab 60mg/1mL solution for injection pre-filled syringe
- Approval Date
- Jul 9, 2025
TGA
EPYZTEK ustekinumab 90 mg/1 mL solution for injection pre-filled syringe (423024)
- Product Name
- EPYZTEK ustekinumab 90 mg/1 mL solution for injection pre-filled syringe
- Approval Date
- Oct 21, 2024
TGA
EPYZTEK ustekinumab 5 mg/1 mL solution for intravenous infusion injection vial (423023)
- Product Name
- EPYZTEK ustekinumab 5 mg/1 mL solution for intravenous infusion injection vial
- Approval Date
- Oct 21, 2024
TGA
EPYZTEK ustekinumab 45 mg/0.5mL solution for injection pre-filled syringe (423022)
- Product Name
- EPYZTEK ustekinumab 45 mg/0.5mL solution for injection pre-filled syringe
- Approval Date
- Oct 21, 2024
TGA
ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial (431837)
- Product Name
- ONBEVZI bevacizumab 100 mg/4mL concentrated injection for intravenous infusion vial
- Approval Date
- Jan 24, 2024
TGA
ONBEVZI bevacizumab 400 mg/16mL concentrated injection for intravenous infusion vial (431838)
- Product Name
- ONBEVZI bevacizumab 400 mg/16mL concentrated injection for intravenous infusion vial
- Approval Date
- Jan 24, 2024
TGA
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe (385133)
- Product Name
- HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe
- Approval Date
- Feb 15, 2023
TGA
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector (384975)
- Product Name
- HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector
- Approval Date
- Feb 15, 2023
TGA
BYOOVIZ ranibizumab 10 mg/mL solution for injection vial (375304)
- Product Name
- BYOOVIZ ranibizumab 10 mg/mL solution for injection vial
- Approval Date
- Aug 24, 2022
TGA
ONTRUZANT trastuzumab 150 mg powder for injection vial (298457)
- Product Name
- ONTRUZANT trastuzumab 150 mg powder for injection vial
- Approval Date
- Jan 9, 2019
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found